Compounds > nitroaspirin
Page last updated: 2024-09-03

nitroaspirin and 6-ketoprostaglandin f1 alpha

nitroaspirin has been researched along with 6-ketoprostaglandin f1 alpha in 3 studies

Compound Research Comparison

Studies
(nitroaspirin)		Trials
(nitroaspirin)		Recent Studies (post-2010)
(nitroaspirin)		Studies
(6-ketoprostaglandin f1 alpha)		Trials
(6-ketoprostaglandin f1 alpha)		Recent Studies (post-2010) (6-ketoprostaglandin f1 alpha)
127984,832294150

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bernareggi, M; Berti, F; Berti, M; Colonna, VD; Del Soldato, P; Rossoni, G1
Bing, RJ; Johnson, PE; Kakar, NR; Vina, ER; Yamamoto, T2

Other Studies

3 other study(ies) available for nitroaspirin and 6-ketoprostaglandin f1 alpha

ArticleYear
Myocardial protection by the nitroderivative of aspirin, NCX 4016: in vitro and in vivo experiments in the rabbit.
    Italian heart journal : official journal of the Italian Federation of Cardiology, 2000, Volume: 1, Issue:2

    Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Aspirin; Creatine Kinase; Dose-Response Relationship, Drug; Electrocardiography; In Vitro Techniques; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Peroxidase; Rabbits; Vasoconstrictor Agents; Ventricular Function, Left

2000
The effect of aspirin and two nitric oxide donors on the infarcted heart in situ.
    Life sciences, 2000, Jul-07, Volume: 67, Issue:7

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Cyclooxygenase Inhibitors; Drug Interactions; Enzyme Activation; Heart Rate; Male; Myocardial Infarction; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rabbits; Thromboxane A2; Triazenes; Ventricular Pressure

2000
Effect of cyclooxygenase-2 inhibitor (celecoxib) on the infarcted heart in situ.
    Pharmacology, 2001, Volume: 63, Issue:1

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Epoprostenol; Heart; Isoenzymes; Male; Myocardial Infarction; Myocardium; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rabbits; Sulfonamides; Thromboxane A2

2001